SCHEMBL30468415

SCHEMBL30468415

CC(C)(C)OC(=O)N1CCc2cc(O)ccc2C2(CC2)C1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 5/20 0.67
NR1H2 P55055 2/20 0.50
USP30 Q70CQ3 1/20 0.43
ESR1 P03372 4/20 0.42
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PDK1 Q15118 1/20 0.39
PDK2 Q15119 1/20 0.39
PDK3 Q15120 1/20 0.39
PDK4 Q16654 1/20 0.39
SCD5 Q86SK9 1/20 0.39
HDAC2 Q92769 1/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
CYP11B2 P19099 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29052411 0.88 ESR2 (0.67) ESR2NR1H2USP30ESR1NPC1
SCHEMBL30468491 0.87 NR1H2 (0.68) ESR2NR1H2USP30NPC1RAB9A
SCHEMBL327558 0.85 ESR2 (0.60) ESR2NR1H2USP30NPC1RAB9A
SCHEMBL30468410 0.84 ESR2 (0.51) ESR2NR1H2USP30SCD5HDAC1
SCHEMBL2132877 0.83 ESR2 (0.84) ESR2NR1H2ESR1NPC1RAB9A
SCHEMBL2500184 0.82 HSD11B1 (0.47) ESR2NR1H2USP30SCD5HDAC2
SCHEMBL30468497 0.81 ESR2 (0.45) ESR2NR1H2USP30ESR1SCD5
SCHEMBL545619 0.81 ESR2 (0.90) ESR2NR1H2ESR1NPC1RAB9A
SCHEMBL450677 0.81 ESR2 (1.00) ESR2NR1H2ESR1NPC1RAB9A
SCHEMBL29590844 0.81 ESR2 (1.00) ESR2NR1H2ESR1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116332910-A 2-aminopyrimidine derivatives as kinase inhibitors, preparation and use thereof 江苏威凯尔医药科技有限公司 2023-06-27 CN disclosed